制酸薬の世界市場:薬物クラス別(プロトンポンプ阻害剤、H2拮抗薬、酸中和剤)、製剤別(錠剤、液体、粉末)、地域別予測

◆英語タイトル:Global Antacid Market Size study, by Drug Class (Proton Pump Inhibitor, H2 Antagonist, And Acid Neutralizers), by Formulation (Tablet, Liquid, And Powder) and Regional Forecasts 2019-2026
◆商品コード:BZW9OT005
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年9月
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥426,600見積依頼/購入/質問フォーム
Enterprisewide(同一法人内共有可)USD5,550 ⇒換算¥599,400見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、制酸薬の世界市場について調べ、制酸薬の世界規模、市場動向、市場環境、薬物クラス別(プロトンポンプ阻害剤、H2拮抗薬、酸中和剤)分析、製剤別(錠剤、液体、粉末)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。
・イントロダクション
・エグゼクティブサマリー
・制酸薬の世界市場概要
・制酸薬の世界市場環境
・制酸薬の世界市場動向
・制酸薬の世界市場規模
・制酸薬の世界市場規模:薬物クラス別(プロトンポンプ阻害剤、H2拮抗薬、酸中和剤)
・制酸薬の世界市場規模:製剤別(錠剤、液体、粉末)
・制酸薬の世界市場:地域別市場規模・分析
・制酸薬の北米市場規模・予測
・制酸薬のアメリカ市場規模・予測
・制酸薬のヨーロッパ市場規模・予測
・制酸薬のアジア市場規模・予測
・制酸薬の日本市場規模・予測
・制酸薬の中国市場規模・予測
・関連企業情報
【レポートの概要】

Antacid Market is valued approximately USD 6.13 billion in 2018 and is anticipated to grow with a healthy growth rate of more than 3.9% over the forecast period 2019-2026. The growingincrease prevalence of gastric diseases has led the healthcare and pharmaceuticals providers towards the development of more enhanced gastric solution to get relief from acidity and heartburns. Antacids are the class of drugs thatwhich reduces gastric acidity resulting in the increase pH of the stomach and duodenum. The growing prevalence of gastric diseases among geriatric population has led to the increase in demand for antacids. The advancement of e-commerce industry coupled with the consumer preference for online medication due to ease of availability of drugs and home delivery services has propelled the demand for antacids. The increasing adoption of self-medication and ease of availability of various over-the-counter antacids has increased the market share of antacids. Moreover, the population of Gastroesophageal reflux disease, or GERD, has increased significantly resulting in the growingincreased demand for antacids. The various factors leading to the gastric diseases are unhealthy diet, lack of proper sleep, and lack of physical activities. This hasve resulted in the accelerated market share of antacids.
The regional analysis of Antacid market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. Asia Pacific region is expected to register considerable growth over the forecast period owing to consumer awareness, rising investment by market players and growing disposable income have increased the market share of antacids. Moreover, availability of effective treatment methods has fostered the demand for antacids.

Major market player included in this report are:
GlaxoSmithKline plc
Bayer AG
Boehringer Ingelheim International GmbH
Sanofi
Pfizer Inc.
Abbott Laboratories
Dabur India Ltd.
GlaxoSmithKline plc
Sun Pharmaceuticals Ltd.
Procter & Gamble
Piramal Enterprises
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Drug Class:
H2 Antagonist
Proton pump inhibitors
Acid neutralizers
By Formulation:
Tablet
Liquid
Powder
By Region:
North America
U.S.
Canada
Europe
UK
Germany
Asia Pacific
China
India
Japan
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2016, 2017
Base year – 2018
Forecast period – 2019 to 2026

Target Audience of the Antacid Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors

【レポートの目次】

Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2017-2026 (USD Billion)
1.2.1. Antacid Market, by Region, 2017-2026 (USD Billion)
1.2.2. Antacid Market, by Drug Class, 2017-2026 (USD Billion)
1.2.3. Antacid Market, by Formulation, 2017-2026 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Antacid Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Antacid Market Dynamics
3.1. Antacid Market Impact Analysis (2018-2026)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Antacid Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2016-2026)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Antacid Market, by Drug Class
5.1. Market Snapshot
5.2. Antacid Market by Drug Class, Performance – Potential Analysis
5.3. Antacid Market Estimates & Forecasts by Drug Class 2016-2026 (USD Billion)
5.4. Polymer Emulsion Market, Sub Segment Analysis
5.4.1. H2 Antagonist
5.4.2. Proton pump inhibitors
5.4.3. Acid neutralizers
Chapter 6. Antacid Market, by Formulation
6.1. Market Snapshot
6.2. Antacid Market by Formulation, Performance – Potential Analysis
6.3. Antacid Market Estimates & Forecasts by Formulation 2016-2026 (USD Billion)
6.4. Polymer Emulsion Market, Sub Segment Analysis
6.4.1. Tablet
6.4.2. Liquid
6.4.3. Powder
Chapter 7. Antacid Market, Regional Analysis
7.1. Antacid Market, Regional Market Snapshot
7.2. North America Antacid Market
7.2.1. U.S. Antacid Market
7.2.1.1. Drug Class breakdown estimates & forecasts, 2016-2026
7.2.1.2. Formulation breakdown estimates & forecasts, 2016-2026
7.2.2. Canada Antacid Market
7.3. Europe Antacid Market Snapshot
7.3.1. U.K. Antacid Market
7.3.2. Rest of Europe Antacid Market
7.4. Asia-Pacific Antacid Market Snapshot
7.4.1. China Antacid Market
7.4.2. India Antacid Market
7.4.3. Japan Antacid Market
7.4.4. Rest of Asia Pacific Antacid Market
7.5. Latin America Antacid Market Snapshot
7.5.1. Brazil Antacid Market
7.5.2. Mexico Antacid Market
7.6. Rest of The World Antacid Market

Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. GlaxoSmithKline plc
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Bayer AG
8.2.3. Boehringer Ingelheim International GmbH
8.2.4. Sanofi
8.2.5. Pfizer Inc.
8.2.6. Abbott Laboratories
8.2.7. Dabur India Ltd.
8.2.8. GlaxoSmithKline plc
8.2.9. Sun Pharmaceuticals Ltd.
8.2.10. Procter & Gamble
8.2.11. Piramal Enterprises
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF ANTACID MARKET
TABLE 3. ANTACID MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. ANTACID MARKET ESTIMATES & FORECASTS BY REGION 2016-2026 (USD BILLION)
TABLE 7. ANTACID MARKET ESTIMATES & FORECASTS BY DRUG CLASS 2016-2026 (USD BILLION)
TABLE 8. ANTACID MARKET ESTIMATES & FORECASTS BY FORMULATION 2016-2026 (USD BILLION)
TABLE 9. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 10. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 11. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 12. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 13. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 14. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 15. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 16. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 17. ANTACID MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 18. ANTACID MARKET BY REGION, ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 19. U.S. ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 20. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 21. U.S. ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 22. CANADA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 23. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 24. CANADA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 25. UK ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 26. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 27. UK ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 28. GERMANY ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 29. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 30. GERMANY ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 31. ROE ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 32. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 33. ROE ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 34. CHINA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 35. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 36. CHINA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 37. INDIA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 38. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 39. INDIA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 40. JAPAN ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 41. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 42. JAPAN ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 43. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 44. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 45. ROAPAC ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 46. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 47. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 48. BRAZIL ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 49. MEXICO ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 50. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 51. MEXICO ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 52. ROLA ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 53. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 54. ROLA ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 55. ROW ANTACID MARKET ESTIMATES & FORECASTS, 2016-2026 (USD BILLION)
TABLE 56. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)
TABLE 57. ROW ANTACID MARKET ESTIMATES & FORECASTS BY SEGMENT 2016-2026 (USD BILLION)

FIG 1. ANTACID MARKET, RESEARCH METHODOLOGY
FIG 2. ANTACID MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. ANTACID MARKET, KEY TRENDS 2018
FIG 5. ANTACID MARKET, GROWTH PROSPECTS 2019-2026
FIG 6. ANTACID MARKET, PORTERS 5 FORCE MODEL
FIG 7. ANTACID MARKET, PEST ANALYSIS
FIG 8. ANTACID MARKET, VALUE CHAIN ANALYSIS
FIG 9. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 10. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 11. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 12. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 13. ANTACID MARKET BY SEGMENT, 2016 & 2026 (USD BILLION)
FIG 14. ANTACID MARKET, REGIONAL SNAPSHOT 2016 & 2026
FIG 15. NORTH AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 16. EUROPE ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 17. ASIA PACIFIC ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 18. LATIN AMERICA ANTACID MARKET 2016 & 2026 (USD BILLION)
FIG 19. ANTACID MARKET, COMPANY MARKET SHARE ANALYSIS (2018)

【掲載企業】

GlaxoSmithKline plc、Bayer AG、Boehringer Ingelheim International GmbH、Sanofi、Pfizer Inc.、Abbott Laboratories、Dabur India Ltd.、GlaxoSmithKline plc、Sun Pharmaceuticals Ltd.、Procter & Gamble、Piramal Enterprises

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[制酸薬の世界市場:薬物クラス別(プロトンポンプ阻害剤、H2拮抗薬、酸中和剤)、製剤別(錠剤、液体、粉末)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆